{"schema_version":"secwatch.filing_event.v1","accession":"0001619856-25-000047","form_type":"8-K","ticker":"CRBU","cik":"0001619856","company_name":"Caribou Biosciences, Inc.","filed_at":"2025-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.049377+00:00","generated_at":"2026-05-19T08:24:35.662497+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Caribou Biosciences stockholders approve reverse stock split authorization at annual meeting","bullets":["Class I directors elected: Scott Braunstein (40.2M votes for) and Ran Zheng (30.4M votes for).","Deloitte & Touche ratified as independent auditor for FY2025 (66.5M for, 1.1M against).","Amendment to charter approved to allow reverse stock split at ratio from 1:5 to 1:50, as determined by board.","Adjournment proposal approved but unnecessary due to quorum and sufficient votes on all proposals."],"urls":{"canonical":"https://secwatch.observer/filing/0001619856-25-000047","json":"https://secwatch.observer/filing/0001619856-25-000047.json","markdown":"https://secwatch.observer/filing/0001619856-25-000047.md","text":"https://secwatch.observer/filing/0001619856-25-000047.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1619856/000161985625000047/0001619856-25-000047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1619856/000161985625000047/crbu-20250612.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T08:24:35.662497+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}